World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile
World Scleroderma Foundation

@worldsclerofnd

The World Scleroderma Foundation is a non-profit, non-governmental foundation based in Switzerland, promoting scleroderma research and supporting patients.

ID: 931259016449331201

linkhttp://www.worldsclerofound.org calendar_today16-11-2017 20:33:46

792 Tweet

1,1K Followers

329 Following

World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

🔷Very Early Diagnosis of SSc:The Window of Opportunity in SSc🔷Early diagnosis is crucial for improving patient outcomes.explores how cutting-edge biomarkers and clinical assessments are shaping early intervention. U.MullerLadner,M.Hughes, F. Del Galdo, S.Belland

🔷Very Early Diagnosis of SSc:The Window of Opportunity in SSc🔷Early diagnosis is crucial for improving patient outcomes.explores how cutting-edge biomarkers and clinical assessments are shaping early intervention. U.MullerLadner,M.Hughes, F. Del Galdo, S.Belland
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

🔷Management of SSc & ILD: Improving SSc Patient Outcomes Through Better Management 🔷This session focuses on risk stratification, ILD progression, and innovative treatment approaches in Systemic Sclerosis. M.E.truchetet, D. Giuggioli,F. Iannone, allanore yannick Dinesh Khanna, A. Doria

🔷Management of SSc & ILD: Improving SSc Patient Outcomes Through Better Management 🔷This session focuses on risk stratification, ILD progression, and innovative treatment approaches in Systemic Sclerosis.
M.E.truchetet, D. Giuggioli,F. Iannone, <a href="/allanore/">allanore yannick</a> Dinesh Khanna, A. Doria
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

🔷Round Table: Immunosuppression in SSc🔷 Balancing Immunosuppression & Autoimmune Control in SSc. This expert roundtable will discuss the complexities of immune modulation, therapy choices, and patient safety in treating SSc.L. Dagna,Y. Allanore, C. Denton, G. Di Colo, D. Khanna

🔷Round Table: Immunosuppression in SSc🔷 Balancing Immunosuppression &amp; Autoimmune Control in SSc. This expert roundtable will discuss the complexities of immune modulation, therapy choices, and patient safety in treating SSc.L. Dagna,Y. Allanore, C. Denton, G. Di Colo, D. Khanna
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

🔷B-Cell Depletion in Autoimmunity:Can B-Cell Targeting Change the Future of Autoimmune Disease? 🔷 Exploring the therapeutic potential of B-cell depletion and its role in autoimmune disease control and long-term remission. P. Rovere Querini, G. Orofino

🔷B-Cell Depletion in Autoimmunity:Can B-Cell Targeting Change the Future of Autoimmune Disease? 🔷 Exploring the therapeutic potential of B-cell depletion and its role in autoimmune disease control and long-term remission. P. Rovere Querini, G. Orofino
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

🔹 Closing Lecture & 20 Years of EUSTAR & WSF: Reflecting on Two Decades of SSc Research & Looking Ahead. A look back at 20 years of advancements in SSc research, collaborations, and the future directions of the World Scleroderma Foundation & EUSTAR .

🔹 Closing Lecture &amp; 20 Years of <a href="/EUSTAR_org/">EUSTAR</a>  &amp; WSF: Reflecting on Two Decades of SSc Research &amp; Looking Ahead. A look back at 20 years of advancements in SSc research, collaborations, and the future directions of the World Scleroderma Foundation &amp; <a href="/EUSTAR_org/">EUSTAR</a> .
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

We extend our sincere gratitude to our sponsors for their valuable contribution to the event. Their commitment to research&innovation is essential in advancing the understanding and treatment of SSc. AbbVie Boehringer Ingelheim @johnsonandjohnson Novartis Takeda GSK GlaxoSmithKline @msd

We extend our sincere gratitude to our sponsors for their valuable contribution to the event. Their commitment to research&amp;innovation is essential in advancing the understanding and treatment of
SSc. <a href="/abbvie/">AbbVie</a> <a href="/Boehringer/">Boehringer Ingelheim</a> @johnsonandjohnson <a href="/Novartis/">Novartis</a> <a href="/TakedaPharma/">Takeda</a>  <a href="/GSK_bio/">GSK GlaxoSmithKline</a> @msd
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

⏳ Final call: WSF Major Grant 2025.The LOI deadline is April 15. Move your ILD research forward with game-changing support from WSF. 📝 Submit your Letter of Intent today to be considered: worldsclerofound.org/major-grant-on… #ILDResearch #WSFGrant #LungFibrosis #FundingOpportunity #SScILD

⏳ Final call: WSF Major Grant 2025.The LOI deadline is April 15. Move your ILD research forward with game-changing support from WSF.
📝 Submit your Letter of Intent today to be considered: worldsclerofound.org/major-grant-on…
#ILDResearch #WSFGrant #LungFibrosis #FundingOpportunity #SScILD
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

⏱ Final hours! The WSF Major Grant 2025 LOI deadline is tomorrow at midnight. Don’t miss this opportunity to advance your ILD research. 📝 Submit your LOI now to be considered. No extensions: worldsclerofound.org/major-grant-on… #WSFGrant #ILDResearch #LungFibrosis #ResearchFunding #SScILD

⏱ Final hours!
The WSF Major Grant 2025 LOI deadline is tomorrow at midnight. Don’t miss this opportunity to advance your ILD research.
📝 Submit your LOI now to be considered.
No extensions: worldsclerofound.org/major-grant-on…

#WSFGrant #ILDResearch #LungFibrosis #ResearchFunding #SScILD
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

📚 April’s top pick from WSF’s Relevant Literature is out! Curated by Dr. Corrado Campochiaro , Dr. Devis Benfaremo & Dr. Ramona Maria Melis—don’t miss this month’s standout research in #SystemicSclerosis. 🔗 worldsclerofound.org/relevant-liter… #Scleroderma #WSF #Research

📚 April’s top pick from WSF’s Relevant Literature is out!
Curated by Dr. <a href="/CorradoCampoch1/">Corrado Campochiaro</a> , Dr. Devis Benfaremo &amp; Dr. Ramona Maria Melis—don’t miss this month’s standout research in #SystemicSclerosis.
🔗 worldsclerofound.org/relevant-liter…
#Scleroderma #WSF #Research
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

Young investigators: The #WSF Starting Grant 2025 offers €30K to 5 researchers under 35 focused on systemic sclerosis. You could be next. ✅ Eligible institution ✅ Research infra ✅ No WSF grant 2023–2024 📝 Apply now:worldsclerofound.org/starting-grant… #Rheumatology #SScResearch #WSFGrant

Young investigators: The #WSF Starting Grant 2025 offers €30K to 5 researchers under 35 focused on systemic sclerosis. You could be next.
✅ Eligible institution
✅ Research infra
✅ No WSF grant 2023–2024
📝 Apply now:worldsclerofound.org/starting-grant…
#Rheumatology #SScResearch #WSFGrant
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

📢 Meet us at #EULAR25 in #Barcelona! 📅 June 11–15 | 📍 Booth O19, Hall 8.1 🎤 Sessions & interviews by @EUSTAR YIG 🤝 WSF Community Area 💡 Apply for our Major & Young Investigator Grants! 🔗 Info: worldsclerofound.org/research/ #Scleroderma #WSF #MedicalResearch #Grants

📢 Meet us at #EULAR25 in #Barcelona!
📅 June 11–15 | 📍 Booth O19, Hall 8.1
🎤 Sessions &amp; interviews by @EUSTAR YIG
🤝 WSF Community Area
💡 Apply for our Major &amp; Young Investigator Grants!
🔗 Info: worldsclerofound.org/research/
#Scleroderma #WSF #MedicalResearch #Grants
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

📚 May's top picks from WSF’s Relevant Literature: 1⃣Heart involvement & cardiac MRI in SSc 2⃣Digital ulcer mgmt guidelines (WSF Ad Hoc) 3⃣Nerandomilast in pulmonary fibrosis 🔗 Read more: worldsclerofound.org/relevant-liter… #Scleroderma #WSF #MedicalResearch #May2025

📚 May's top picks from WSF’s Relevant Literature:

1⃣Heart involvement &amp; cardiac MRI in SSc

2⃣Digital ulcer mgmt guidelines (WSF Ad Hoc)

3⃣Nerandomilast in pulmonary fibrosis

🔗 Read more: worldsclerofound.org/relevant-liter…
#Scleroderma #WSF #MedicalResearch #May2025
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

📢 Meet us at #EULAR2025 in Barcelona! 3 day to go 📅 June 11–15 | 📍 Booth O19, Hall 8.1 🎤 Sessions & interviews by EUSTAR YIG 🤝 WSF Membership Area 💡 Apply for our Major & Young Investigator Grants! 🔗 Info:worldsclerofound.org/research/ #Scleroderma #WSF #MedicalResearch #Grants

📢 Meet us at #EULAR2025 in Barcelona! 3 day to go 
📅 June 11–15 | 📍 Booth O19, Hall 8.1
🎤 Sessions &amp; interviews by EUSTAR YIG
🤝 WSF Membership Area
💡 Apply for our Major &amp; Young Investigator Grants!
🔗 Info:worldsclerofound.org/research/
#Scleroderma #WSF #MedicalResearch #Grants
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

#EULAR2025 is LIVE in Barcelona! 🇪🇸 Come see us at Booth O19, Hall 8.1 🌍 🎤 Science sessions 🎥 Live interviews 💡 Grant opportunities Join the World Scleroderma Foundation& get the latest in #Scleroderma research!🔗 worldsclerofound.org/research/ #EUSTAR #MedicalResearch #WSF #Grants

#EULAR2025 is LIVE in Barcelona! 🇪🇸
Come see us at Booth O19, Hall 8.1 🌍
🎤 Science sessions
🎥 Live interviews
💡 Grant opportunities
Join the World Scleroderma Foundation&amp; get the latest in #Scleroderma research!🔗 worldsclerofound.org/research/
#EUSTAR #MedicalResearch #WSF #Grants
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

🎤 Prof. allanore yannick 🇫🇷 presenting NOW at #EULAR2025 in Barcelona! 📚 Topic: Refractory Anemia in Systemic Sclerosis 📍 Room D1 | Session:Managing difficult SSc casesLearn from one of the leading experts in the field. Don’t miss it! #SystemicSclerosis #WSF #EUSTAR

🎤 Prof. <a href="/allanore/">allanore yannick</a>  🇫🇷 presenting NOW at #EULAR2025 in Barcelona! 📚 Topic: Refractory Anemia in Systemic Sclerosis 📍 Room D1 | Session:Managing difficult SSc casesLearn from one of the leading experts in the field. Don’t miss it!  #SystemicSclerosis #WSF #EUSTAR
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

🎤 Prof. Michael Hughes 🇬🇧 presenting NOW at #EULAR2025 in Barcelona! 📚 Topic: WSF expert recommendations on managing refractory GERD in SSc 📍 Room D1 | Session: Managing tough SSc manifestations. New insights from the WSF GI Ad Hoc Committee—don’t miss this!#Scleroderma

🎤 Prof. Michael Hughes 🇬🇧 presenting NOW at #EULAR2025 in Barcelona! 📚 Topic: WSF expert recommendations on managing refractory GERD in SSc
📍 Room D1 | Session: Managing tough SSc manifestations. New insights from the WSF GI Ad Hoc Committee—don’t miss this!#Scleroderma
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

🌞 Good morning from Barcelona – it’s Day 2 of #EULAR2025! 📍 Visit us at Booth O19 | Hall 8.1 🎤 Live sessions 🎥 Expert interviews 💡 Grant opportunities Stay tuned for today’s highlights! #Scleroderma #WSF #EUSTAR #MedicalResearch #HealthcareInnovation

🌞 Good morning from Barcelona – it’s Day 2 of #EULAR2025!
📍 Visit us at Booth O19 | Hall 8.1
🎤 Live sessions
🎥 Expert interviews
💡 Grant opportunities
Stay tuned for today’s highlights!
#Scleroderma #WSF #EUSTAR #MedicalResearch #HealthcareInnovation
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

📊 Today at #EULAR2025 | 10:30–12:00 CEST 📍 Room 6.4 🗂️ Oral Abstracts: Insights from Registries in SSc 💡 Early indicators, antibody phenotypes, calcinosis, cancer risk, & AI-driven screening Speakers: Di Donato | Colic | Moschetti | Guler | Tonutti #Scleroderma #EUSTAR #WSF

📊 Today at #EULAR2025 | 10:30–12:00 CEST
📍 Room 6.4
🗂️ Oral Abstracts: Insights from Registries in SSc
💡 Early indicators, antibody phenotypes, calcinosis, cancer risk, &amp; AI-driven screening
Speakers: Di Donato | Colic | Moschetti | Guler | Tonutti
#Scleroderma #EUSTAR #WSF
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

🤝 Meet the Expert at #EULAR2025! 📍 Expert Room 2 🎓 Prof. Marco Matucci-Cerinic 🇮🇹 on Managing Vasculopathy in SSc 💡 Deep dive into diagnostics, treatment & real-world care strategies. Don’t miss this interactive session! #Scleroderma #WSF #Rheumatology #SystemicSclerosis

🤝 Meet the Expert at #EULAR2025!
📍 Expert Room 2
🎓 Prof. Marco Matucci-Cerinic 🇮🇹 on Managing Vasculopathy in SSc
💡 Deep dive into diagnostics, treatment &amp; real-world care strategies.
Don’t miss this interactive session!
#Scleroderma #WSF #Rheumatology #SystemicSclerosis
World Scleroderma Foundation (@worldsclerofnd) 's Twitter Profile Photo

Day 3 at #EULAR2025 in vibrant Barcelona 🇪🇸 and the energy at the WSF/EUSTAR booth (#O19) is incredible! 💬🤝 Insightful talks, inspiring connections, and a shared passion for #SystemicSclerosis care. Stop by and say hola! 👋 #WSF #EUSTAR #Rheumatology #Barcelona2025

Day 3 at #EULAR2025 in vibrant Barcelona 🇪🇸 and the energy at the WSF/EUSTAR booth (#O19) is incredible! 💬🤝 Insightful talks, inspiring connections, and a shared passion for #SystemicSclerosis care.
Stop by and say hola! 👋 #WSF #EUSTAR #Rheumatology  #Barcelona2025